Project 4 continues to probe (1) what mutagens and other potential toxicants are in the air we breathe and (2) what is the effect of these respirable toxicants on our lungs. The major objectives of Project 4 are threefold: (1) the determination of DNA-adducts in human cell models and human lung, (2) the physico-chemical characterization of respirable particles in human lung, and (3) the detailed structural elucidation of mutagens found in respirable particles. The strategy for the determination and identification of DNA adducts has three principal parts which will take place concurrently. In the first part, we will use an existing method developed in our laboratory involving fluorescence post-labeling and capillary electrophoresis to detect DNA adducts in human lung tissue. In the second part of our work, we will extend this fluorescence post-labeling method in terms of selectivity and sensitivity and also develop laser desorption Fourier transform mass spectrometry (C0/2-LD-FTMS) as a complementary technique for detection of the fluorophore-labeled DNA adducts. The third part involves the continued adaptation of a promising method, muHPLC/FL developed during the current period of performance of this project. The measurement of DNA adducts is important for human health because lung cancer is a prevalent and virtually incurable disease and the evidence is overwhelming that DNA adducts are associated with cancer. Research on particle characterization proposed here is based on the application of an innovative method, developed at NIT, for quantification of the fine structure of carbon-based and other respirable particulate matter utilizing high resolution transmission electron microscopy (HRTEM) and scanning transmission electron microscopy (STEM) coupled with electron energy loss spectroscopy (EELS) and energy dispersive X-ray analysis (EDX). The tasks associated with Specific Aim 2 are organized into three main areas: (1) particle imaging in human lung by HRTEM; (2) particle characterization by EELS and EDX and (3) source identification and apportionment. Our third objective is the detailed structural elucidation of compounds sampled in Project 1 and determined in Project 2 to be important human cell mutagens. Work to date has shown that the semi-polar fraction accounts for up to one-half or more of the total mutagenicity of respirable air particles and we will be focusing our efforts on this class of mutagens. Investigators will also collaborate in the characterize respirable particles and aerosols emitted from natural gas combustors and propose to determine what components in the emissions from these combustors are responsible for the heightened mutagenicity of these samples.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Program Projects (P01)
Project #
5P01ES007168-06
Application #
6338777
Study Section
Project Start
2000-08-03
Project End
2003-07-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
6
Fiscal Year
2000
Total Cost
$222,065
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Zheng, Weiming; Khrapko, Konstantin; Coller, Hilary A et al. (2006) Origins of human mitochondrial point mutations as DNA polymerase gamma-mediated errors. Mutat Res 599:11-20
Coller, Hilary A; Khrapko, Konstantin; Herrero-Jimenez, Pablo et al. (2005) Clustering of mutant mitochondrial DNA copies suggests stem cells are common in human bronchial epithelium. Mutat Res 578:256-71
Pedersen, Daniel U; Durant, John L; Taghizadeh, Koli et al. (2005) Human cell mutagens in respirable airborne particles from the northeastern United States. 2. Quantification of mutagens and other organic compounds. Environ Sci Technol 39:9547-60
Pedersen, Daniel U; Durant, John L; Penman, Bruce W et al. (2004) Human-cell mutagens in respirable airborne particles in the northeastern United States. 1. Mutagenicity of fractionated samples. Environ Sci Technol 38:682-9
Tomita-Mitchell, Aoy; Ling, Losee Lucy; Glover, Curtis L et al. (2003) The mutational spectrum of the HPRT gene from human T cells in vivo shares a significant concordant set of hot spots with MNNG-treated human cells. Cancer Res 63:5793-8
Luo, Wen; Gurjuar, Rajan; Ozbal, Can et al. (2003) Quantitative detection of benzo[alpha]pyrene diolepoxide-DNA adducts by cryogenic laser induced fluorescence. Chem Res Toxicol 16:74-80
Kim, Andrea S; Thilly, William G (2003) Ligation of high-melting-temperature 'clamp' sequence extends the scanning range of rare point-mutational analysis by constant denaturant capillary electrophoresis (CDCE) to most of the human genome. Nucleic Acids Res 31:e97
Muniappan, Brindha P; Thilly, William G (2002) The DNA polymerase beta replication error spectrum in the adenomatous polyposis coli gene contains human colon tumor mutational hotspots. Cancer Res 62:3271-5
Kim, Andrea S; Holmquist, Gerald P; Thilly, William G (2002) High-efficiency DNA ligation for clamp attachment without polymerase chain reaction. Anal Biochem 310:179-85
Zheng, Weiming; Marcelino, Luisa A; Thilly, William G (2002) Scanning low-frequency point mutants in the mitochondrial genome using constant denaturant capillary electrophoresis. Methods Mol Biol 197:93-106

Showing the most recent 10 out of 36 publications